PGR and cancer: Some proteins are already well known in cancer studies in relation to molecular diagnosis and treatment with monoclonal antibodies, for example, estrogen and progesterone receptors, vascular endothelial growth factor receptor (VEGFR), EGFR and HER2 [66].